[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336068-105":59,"doc-detail-336068-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","critical-and-distinct-roles-of-cell-typespecific-nf-b2-in-lung-cancer","Critical and distinct roles of cell type–specific NF-κB2 in lung cancer","","NF-κB is linked to human cancers, particularly lung cancer, and its activation influences tumor survival, proliferation, invasion, metastasis, immune evasion, angiogenesis, and cancer-related inflammation. While the canonical NF-κB member RelA and general NF-κB targeting have been widely studied, the specific role of the noncanonical NF-κB member NF-κB2 in lung cancer remains poorly defined. This work reports that intrinsic NF-κB2 in lung epithelial and tumor cells does not strongly alter tumor initiation or progression. Instead, NF-κB2 regulates dendritic cell number and activation, while protecting macrophages and promoting lung cancer by coordinating noncanonical versus canonical NF-κB activity. NF-κB2 is also necessary for B cell maintenance and T cell activation, yielding an overall tumor-promoting balance dominated by myeloid NF-κB2.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/critical-and-distinct-roles-of-cell-typespecific-nf-b2-in-lung-cancer/336068/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/critical-and-distinct-roles-of-cell-typespecific-nf-b2-in-lung-cancer/336068.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about NF-κB2 in lung cancer?","Question",{"text":112,"@type":113},"It investigates how the noncanonical NF-κB member NF-κB2 contributes to lung cancer, especially in a cell type–specific manner, given that RelA and NF-κB targeting are better understood.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does intrinsic NF-κB2 in lung epithelial and tumor cells affect tumorigenesis?",{"text":117,"@type":113},"Intrinsic NF-κB2 intrinsic to lung epithelial and tumor cells shows no marked effect on lung tumorigenesis and progression compared with RelA’s tumor-promoting role.",{"name":119,"@type":110,"acceptedAnswer":120},"Which immune cell compartments drive the overall tumor-promoting activity of NF-κB2?",{"text":121,"@type":113},"The antitumor activity from lymphocyte NF-κB2 is dominated by protumor functions of myeloid NF-κB2, making NF-κB2 overall tumor-promoting.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336068,1790093919,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":4},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","RESE AR CH  \nARTICLE  \nConflict of interest: The authors have declared that no conflict of interest exists.  \nCopyright: © 2024, Sun et al. This isan open access article published under the terms of the Creative Commons Attribution 4.0 International License.  \nSubmitted: August 3, 2022  \nAccepted: January 17, 2024  \nPublished: February 22, 2024  \nReference information: JCI Insight. 2024;9(4):e164188 .  \n[https://doi.org/10.1172/jci](https://doi.org/10.1172/jci).  \ninsight.164188 .  \nCritical and distinct roles of cell type–specific NF-κB2 in lung cancer  \nFan Sun,1 Yadong Xiao,1,2,3,4 Steven D. Shapiro,3,4 Zhaoxia Qu,1,2 and Gutian Xiao1,2  \n1UPMC Hillman Cancer Center, Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. 2Norris Comprehensive Cancer Center, Hastings Center for Pulmonary Research, Department of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, California, USA. 3Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. 4Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, California, USA.  \nDifferent from the well-studied canonical NF-κB member RelA, the role of the noncanonical NF-κB member NF-κB2 in solid tumors, and lung cancer in particular, is poorly understood. Here we report that in contrast to the tumor-promoting role of RelA, NF-κB2 intrinsic to lung epithelial and tumor cells had no marked effect on lung tumorigenesis and progression. On the other hand, NF-κB2 limited dendritic cell number and activation in the lung but protected lung macrophages and drove them to promote lung cancer through controlling activation of noncanonical and canonical NF-κB, respectively. NF-κB2 was also required for B cell maintenance and T cell activation. The antitumor activity of lymphocyte NF-κB2 was dominated by the protumor function of myeloid NF-κB2; thus, NF-κB2 has an overall tumor-promoting activity. These studies reveal a cell type–dependent role for NF-κB2 in lung cancer and help understand the complexity of NF-κB action and lung cancer pathogenesis for better design of NF-κB–targeted therapy against this deadliest cancer.  \nIntroduction  \nThe master transcription factor NF-κB has been linked to almost all human cancers and in particular lung cancer, the second most common cancer type and the leading cause of cancer-related deaths, with a 5-year survival rate of only 22% and annual deaths of over 130,000 Americans (1–3) . Aberrant NF-κB activation has been suggested to be involved in the full process of tumor development, from initiation to metastasis, as well as cancer therapy resistance (1, 2) . Mechanistically, NF-κB contributes to tumor pathogenesis, both intrinsically and extrinsically. Within precancerous or cancerous cells, activated NF-κB regulates a wide range of genes not only to promote malignant cell survival, proliferation, invasion, metastasis, and immune evasion, but also to induce angiogenesis and tumorigenic inflammation (1, 2) . Moreover, NF-κB activated in tumor-associated cells, particularly immune cells, contributes to tumor pathogenesis indirectly through establishing a protumorigenic microenvironment (4, 5) . Accordingly, it is not surprising that NF-κB and in particular its key activator, IKK kinase, has been a target of great interest for tumor therapy during the past several decades (6) . However, we have been unable to successfully target it for therapy due to its functional complexities (6, 7) .  \nNF-κB is not a single protein, but refers to 5 structurally related transcription factors: NF-κB1, NF-κB2, RelA (also known as p65), RelB, and c-Rel (1, 2) . The tumorigenic roles of NF-κB in lung and other cancers are largely derived from the antitumor effects of NF-κB inhibition by administration of IKK inhibitors, ","cbCaiqESPZw8SWJh","https://ap.wps.com/l/cbCaiqESPZw8SWJh","pdf",3768623,16,"English","# Introduction\n## NF-κB and lung cancer background\n## NF-κB family diversity and functional complexity\n## Need to define NF-κB2 roles\n# Cell type–specific NF-κB2 functions in lung cancer\n## Effects on lung epithelial and tumor cells\n## Effects on dendritic cells and macrophages\n## Impact on B cells and T cell activation","[{\"question\":\"What question does the study address about NF-κB2 in lung cancer?\",\"answer\":\"It investigates how the noncanonical NF-κB member NF-κB2 contributes to lung cancer, especially in a cell type–specific manner, given that RelA and NF-κB targeting are better understood.\"},{\"question\":\"How does intrinsic NF-κB2 in lung epithelial and tumor cells affect tumorigenesis?\",\"answer\":\"Intrinsic NF-κB2 intrinsic to lung epithelial and tumor cells shows no marked effect on lung tumorigenesis and progression compared with RelA’s tumor-promoting role.\"},{\"question\":\"Which immune cell compartments drive the overall tumor-promoting activity of NF-κB2?\",\"answer\":\"The antitumor activity from lymphocyte NF-κB2 is dominated by protumor functions of myeloid NF-κB2, making NF-κB2 overall tumor-promoting.\"}]","Critical and distinct roles of cell type–specific NF-κB2 in lung cancer | PDF",1790013480]